Drug Trial Radar · NCT01567852
Use of Ketamine vs Methohexital for Electroconvulsive Therapy (ECT) on Patient Recovery and Re-orientation Time
Last checked: Nov 20, 2026Latest source record: Dec 30, 2014 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
20
Actual
Start
Aug 2011
Primary completion
Mar 2013
Study completion Mar 2013
Sponsor
- Lead sponsor
- University of New MexicoAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Mar 30, 2012
Design
- Study type
- Interventional
- Phase
- Not applicable
- Allocation
- Randomized
- Model
- Crossover
- Masking
- Double (participant, outcomes assessor)
- Primary purpose
- Treatment
- Who can join
- All sexes
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
When undergoing ECT treatments, patient recovery time and re-orientation time may be shorter using ketamine for induction than using methohexital.
Conditions
- Post-anesthesia Recovery
- Orientation
Interventions
KetamineDrug
Ketamine (1.5mg/kg) will be given for induction, with room to titrate up to induction effect
MethohexitalDrug
Methohexital (1.5mg/kg) will be given for induction
Primary outcomes
What the sponsor says the trial is designed to measure.
- Re-orientation TimeTime frame: 1 hour
- Recovery TimeTime frame: 1 hour
Locations
1 site in 1 country. Site status is shown where the registry gives one.
University of New Mexico
Albuquerque, New Mexico
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.